SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950142-22-001869
Filing Date
2022-06-10
Accepted
2022-06-10 16:10:02
Documents
2
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT es220259990_3-harjivan.html 3  
1 OWNERSHIP DOCUMENT es220259990_3-harjivan.xml 3 1599
2 EXHIBIT 24 es220259990_3-ex24.htm EX-24 8014
  Complete submission text file 0000950142-22-001869.txt   11114
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Issuer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VTV THERAPEUTICS INC. 3980 PREMIER DRIVE HIGH POINT NC 27265
Business Address
Harjivan Chandresh (Reporting) CIK: 0001932607 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37524 | Film No.: 221008938